Skip to main content
. 2021 Nov 15;15(6):827–840. doi: 10.5009/gnl20367

Fig. 2.

Fig. 2

Future directions.

NAFLD, nonalcoholic fatty liver disease; NASH, nonalcoholic steatohepatitis; HCC, hepatocellular carcinoma.